Financials Fujian Aonong Biological Technology Group Incorporation Limited

Equities

603363

CNE100002VK6

Fishing & Farming

End-of-day quote Shanghai S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
3.64 CNY +2.82% Intraday chart for Fujian Aonong Biological Technology Group Incorporation Limited -3.70% -40.03%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 3,578 6,878 8,351 8,692 11,228 3,168 3,168 -
Enterprise Value (EV) 1 3,578 6,878 8,351 8,692 11,228 3,168 3,168 3,168
P/E ratio 120 x 226 x 13 x -5.43 x -9.62 x -3.73 x 2.09 x 2.27 x
Yield - - - - - - - -
Capitalization / Revenue 0.62 x 1.19 x - 0.48 x 0.52 x 0.12 x 0.1 x 0.09 x
EV / Revenue 0.62 x 1.19 x - 0.48 x 0.52 x 0.12 x 0.1 x 0.09 x
EV / EBITDA - - - - - - - -
EV / FCF - - - - -13.7 x -1.86 x 1.89 x 1.58 x
FCF Yield - - - - -7.32% -53.8% 52.8% 63.3%
Price to Book 4.4 x - - 7.53 x 4.48 x 1.83 x 0.98 x 0.68 x
Nbr of stocks (in thousands) 553,775 564,468 674,016 684,413 871,058 870,275 870,275 -
Reference price 2 6.462 12.18 12.39 12.70 12.89 3.540 3.540 3.540
Announcement Date 4/30/19 4/9/20 3/24/21 4/29/22 4/28/23 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 5,762 5,788 - 18,038 21,613 26,628 31,990 34,523
EBITDA - - - - - - - -
EBIT 1 21.59 - - -1,807 -1,311 -991 1,771 1,639
Operating Margin 0.37% - - -10.02% -6.07% -3.72% 5.54% 4.75%
Earnings before Tax (EBT) 1 19.88 - - -1,822 -1,295 -986 1,781 1,659
Net income 1 30.13 - 573 -1,520 -1,039 -824 1,469 1,362
Net margin 0.52% - - -8.43% -4.81% -3.09% 4.59% 3.95%
EPS 2 0.0538 0.0538 0.9500 -2.340 -1.340 -0.9500 1.690 1.560
Free Cash Flow 1 - - - - -821.5 -1,704 1,673 2,005
FCF margin - - - - -3.8% -6.4% 5.23% 5.81%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - 113.89% 147.21%
Dividend per Share 2 - - - - - - - -
Announcement Date 4/30/19 4/9/20 3/24/21 4/29/22 4/28/23 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - - -821 -1,704 1,673 2,005
ROE (net income / shareholders' equity) 4.97% - - -74.1% -49.8% -49% 47% 30%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 1.470 - - 1.690 2.870 1.930 3.620 5.180
Cash Flow per Share 0.0500 - - - - - - -
Capex 1 563 - - 2,697 1,485 2,301 1,370 1,524
Capex / Sales 9.77% - - 14.95% 6.87% 8.64% 4.28% 4.41%
Announcement Date 4/30/19 4/9/20 3/24/21 4/29/22 4/28/23 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.64
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603363 Stock
  4. Financials Fujian Aonong Biological Technology Group Incorporation Limited